NCT03033082 is a clinical trial of Questionnaire sheets in Erectile Dysfunction, sponsored by Adam International Hospital.

Who is sponsoring NCT03033082?

NCT03033082 is sponsored by Adam International Hospital.

What drugs are being tested in NCT03033082?

Interventions in NCT03033082: Questionnaire sheets.

What condition does NCT03033082 study?

NCT03033082 studies Erectile Dysfunction.

Is NCT03033082 still recruiting?

NCT03033082 is currently completed. Last updated 26 January 2017.

Last reviewed 2017-01-26 · How we verify

NCT03033082

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Marital and Sexual Satisfaction of Wives to Erectile Dysfunction Males

Completed Last updated 26 January 2017

What this trial tests

trial testing Questionnaire sheets in Erectile Dysfunction in 70 participants. Completed in 30 June 2014.

Timeline

1 January 2014

Primary endpoint
1 June 2014

30 June 2014

Quick facts

Lead sponsor	Adam International Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	70
Start date	1 January 2014
Primary completion	1 June 2014
Estimated completion	30 June 2014

Drugs / interventions tested

Questionnaire sheets

Conditions studied

Erectile Dysfunction — all drugs for Erectile Dysfunction →

Sponsor

Adam International Hospital

Who can join

Adults 18 to 50, any sex, with Erectile Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Erectile Dysfunction (ED), previously known as sexual impotence, is defined as the persistent inability to obtain and/or maintain a penile erection that is hard enough for satisfactory sexual intercourse. The number of reported patients with ED is increasing and it is becoming a real medical problem.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Erectile Dysfunction

Currently open trials in the same condition.

NCT07442396 — The Effectiveness of Exercise in the Treatment of Erectile Dysfunction and Premature Ejaculation · NA · recruiting
NCT07366970 — Is There a Benefit From Addition of Exercise in Diabetic Patients With ED Who Complain Low Vitamin D? · NA · recruiting
NCT06960746 — Changing Lifestyle in OSA Males Who Suffer Metabolic Syndrome and Impotence: Is There a Response? · NA · recruiting
NCT06872866 — The Objective of This Phase 1 Study is to Evaluate the Food Effect of 100 mg Hezkue Turbo® (ASP-001.1, Sildenafil) Under · Phase 1 · recruiting
NCT06805513 — Actual Use Trial of Tadalafil 5 mg · Phase 3 · recruiting

Other Adam International Hospital trials

Trials by the same sponsor.

NCT03038659 — Role of Intima-media Thickness in Determining Arteriogenic Erectile Dysfunction · completed
NCT03033537 — Intracavernosal Injection of Papaverine/Verapamil Versus Papaverine/Phentolamine in Erectile Dysfunction · completed
NCT03033563 — ICSI Outcome of Ejaculated Versus Extracted Testicular Spermatozoa · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03033082 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Adam International Hospital
Last refreshed: 26 January 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03033082.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing